{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:32:33Z","timestamp":1793323953189,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bcp.2023.115445","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T11:56:10Z","timestamp":1675338970000},"page":"115445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases"],"prefix":"10.1016","volume":"209","author":[{"given":"Christian","family":"Bailly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Thuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115445_b0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri1111","article-title":"The TIM gene family: emerging roles in immunity and disease","volume":"3","author":"Kuchroo","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/imr.12933","article-title":"Regulatory B cells: TIM-1, transplant tolerance, and rejection","volume":"299","author":"Cherukuri","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2023.115445_b0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tim.2019.10.004","article-title":"Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions","volume":"28","author":"Evans","year":"2020","journal-title":"Trends. Microbiol."},{"key":"10.1016\/j.bcp.2023.115445_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.17691\/stm2021.13.3.08","article-title":"Kidney Injury Molecule 1 (KIM-1): a Multifunctional Glycoprotein and Biological Marker (Review)","volume":"13","author":"Karmakova","year":"2021","journal-title":"Sovrem. Tekhnologii. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CBM-210114","article-title":"Role of TIM-3 in regulating tumorigenesis, inflammation, and antitumor immunity therapy","volume":"32","author":"Cao","year":"2021","journal-title":"Cancer. Biomark."},{"key":"10.1016\/j.bcp.2023.115445_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MOT.0000000000000487","article-title":"Diverse roles of TIM4 in immune activation: implications for alloimmunity","volume":"23","author":"McGrath","year":"2018","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"10.1016\/j.bcp.2023.115445_b0035","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1080\/21645515.2015.1056953","article-title":"TIM-3 and TIM-4 as the potential targets for antitumor therapy","volume":"11","author":"Cheng","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bcp.2023.115445_b0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fimmu.2020.00537","article-title":"TIM-4 in Health and Disease: Friend or Foe?","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0045","doi-asserted-by":"crossref","first-page":"e0330921","DOI":"10.1128\/mbio.03309-21","article-title":"Leishmania donovani Impedes Antileishmanial Immunity by Suppressing Dendritic Cells via the TIM-3 Receptor","volume":"13","author":"Akhtar","year":"2022","journal-title":"mBio."},{"key":"10.1016\/j.bcp.2023.115445_b0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"TIM-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2023.115445_b0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2174\/0929867328666210806120904","article-title":"Structure and Functions of T-cell Immunoglobulin-domain and Mucin- domain Protein 3 in Cancer","volume":"29","author":"Lu","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2023.115445_b0065","doi-asserted-by":"crossref","unstructured":"Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2015;517(7534):386-90. Corrigendum in Nature. 2016;536:359.","DOI":"10.1038\/nature13848"},{"key":"10.1016\/j.bcp.2023.115445_b0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/eji.201948400","article-title":"TIM-3 and CEACAM1 do not interact in cis and in trans","volume":"50","author":"De Sousa","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fimmu.2016.00229","article-title":"TIM-3 Regulates Distinct Functions in Macrophages","volume":"7","author":"Oca\u00f1a-Guzman","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0080","doi-asserted-by":"crossref","first-page":"e000911","DOI":"10.1136\/jitc-2020-000911","article-title":"TIM-3 finds its place in the cancer immunotherapy landscape","volume":"8","author":"Acharya","year":"2020","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.bcp.2023.115445_b0085","first-page":"15","article-title":"Prospects of TIM-3 as a Promising Diagnostic and Prognostic Biomarker for Cancer Patients","volume":"31","author":"Chen","year":"2021","journal-title":"Discov. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/ijms18030645","article-title":"TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action","volume":"18","author":"Du","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14737140.2021.1865814","article-title":"TIM-3 pathway dysregulation and targeting in cancer","volume":"21","author":"Zeidan","year":"2021","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.bcp.2023.115445_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105329","article-title":"Cancer cell intrinsic TIM-3 induces glioblastoma progression","volume":"25","author":"Guo","year":"2022","journal-title":"iScience."},{"key":"10.1016\/j.bcp.2023.115445_b0105","doi-asserted-by":"crossref","first-page":"564","DOI":"10.21147\/j.issn.1000-9604.2020.05.02","article-title":"Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-\u03baB\/STAT3 signalling pathway in breast cancer cells","volume":"32","author":"Cong","year":"2020","journal-title":"Chin. J. Cancer. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107933","article-title":"TIM-3: An update on immunotherapy","volume":"99","author":"Zhao","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115445_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101302","article-title":"Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance","volume":"42","author":"Tang","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0120","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1111\/cas.15042","article-title":"TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways","volume":"112","author":"Kikushige","year":"2021","journal-title":"Cancer. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0125","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.723238","article-title":"The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy","volume":"11","author":"Cong","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.753677","article-title":"TIM-3 in Leukemia; Immune Response and Beyond","volume":"11","author":"Rezaei","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0140","article-title":"One Stone, Two Birds: The Roles of TIM-3 in Acute Myeloid Leukemia","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11912-022-01218-y","article-title":"New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors","volume":"24","author":"Gomes de Morais","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bcp.2023.115445_b0150","doi-asserted-by":"crossref","first-page":"e13197","DOI":"10.1111\/sji.13197","article-title":"The prospect of targeting T cell immunoglobulin and mucin-domain containing-3 in renal cell carcinoma immunotherapy","volume":"96","author":"Mohsenzadegan","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0155","doi-asserted-by":"crossref","first-page":"1744921","DOI":"10.1080\/2162402X.2020.1744921","article-title":"Identification and characterization of M6903, an antagonistic anti-TIM-3 monoclonal antibody","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bcp.2023.115445_b0160","doi-asserted-by":"crossref","unstructured":"Curigliano G, Gelderblom H, Mach N, Doi T, Tai D, Forde PM, Sarantopoulos J, Bedard PL, Lin CC, Hodi FS, Wilgenhof S, Santoro A, Sabatos-Peyton CA, Longmire TA, Xyrafas A, Sun H, Gutzwiller S, Manenti L, Naing A. Phase I\/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors. Clin Cancer Res. 2021;27:3620-3629.","DOI":"10.1158\/1078-0432.CCR-20-4746"},{"key":"10.1016\/j.bcp.2023.115445_b0165","doi-asserted-by":"crossref","first-page":"ltac019","DOI":"10.1093\/immadv\/ltac019","article-title":"Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor","volume":"2","author":"Schwartz","year":"2022","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.bcp.2023.115445_b0170","doi-asserted-by":"crossref","unstructured":"Hellmann MD, Bivi N, Calderon B, Shimizu T, Delafontaine B, Liu ZT, Szpurka AM, Copeland V, Hodi FS, Rottey S, Aftimos P, Piao Y, Gandhi L, Galvao VR, Leow CC, Doi T. Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors. Clin Cancer Res. 2021;27:2773-2781.","DOI":"10.1158\/1078-0432.CCR-20-3716"},{"key":"10.1016\/j.bcp.2023.115445_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845499","article-title":"Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function","volume":"13","author":"Blaeschke","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0180","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/1535-7163.MCT-20-0155","article-title":"Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells","volume":"20","author":"Lee","year":"2021","journal-title":"Mol. Cancer. Ther."},{"key":"10.1016\/j.bcp.2023.115445_b0185","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.ymthe.2017.06.023","article-title":"A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice","volume":"25","author":"Gefen","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2023.115445_b0190","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1021\/acs.jmedchem.1c01336","article-title":"Fragment-Based Discovery of Small Molecules Bound to T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (TIM-3)","volume":"64","author":"Rietz","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2023.115445_b0195","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v22.i7.2294","article-title":"Role of TIM-3 in hepatitis B virus infection: An overview","volume":"22","author":"Liu","year":"2016","journal-title":"World. J. Gastroenterol."},{"key":"10.1016\/j.bcp.2023.115445_b0200","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jri.2016.10.113","article-title":"TIM-3: Expression on immune cells and roles at the maternal-fetal interface","volume":"118","author":"Hu","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0205","doi-asserted-by":"crossref","first-page":"e12825","DOI":"10.1111\/sji.12825","article-title":"TIM-3: An emerging target in the liver diseases","volume":"91","author":"Zhao","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106792","article-title":"Contribution of the TIM-3\/Gal-9 immune checkpoint to tropical parasitic diseases","volume":"238","author":"Bailly","year":"2023","journal-title":"Acta. Trop."},{"key":"10.1016\/j.bcp.2023.115445_b0215","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/cells11142249","article-title":"Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"11","author":"Abaza","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2023.115445_b0220","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.urolonc.2021.05.039","article-title":"The prognostic and clinicopathological significance of TIM-3 and PD-1 expression in the prognosis of upper urinary tract urothelial carcinoma","volume":"39","author":"Chen","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0225","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.2147\/CMAR.S328312","article-title":"Clinical Value of Combined Detection of Serum sTIM-3 and Pepsinogen for Gastric Cancer Diagnosis","volume":"13","author":"Chen","year":"2021","journal-title":"Cancer. Manag. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0230","article-title":"Natural Killer Cells Induce CD8+ T Cell Dysfunction via Galectin-9\/TIM-3 in Chronic Hepatitis B Virus Infection","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0235","first-page":"190","article-title":"TIM-3 gene is highly expressed in ephithelial ovarian cancer to promote proliferation and migration of ovarian cancer cells","volume":"42","author":"Huo","year":"2022","journal-title":"Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao."},{"key":"10.1016\/j.bcp.2023.115445_b0240","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/cas.15314","article-title":"Exosomes reveal the dual nature of radiotherapy in tumor immunology","volume":"113","author":"Hu","year":"2022","journal-title":"Cancer. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0245","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2018.02.114","article-title":"Expression profiles and clinical value of plasma exosomal TIM-3 and Galectin-9 in non-small cell lung cancer","volume":"498","author":"Gao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2023.115445_b0250","first-page":"56","article-title":"The roles of exosomal immune checkpoint proteins in tumors","volume":"8","author":"Xing","year":"2021","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0255","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arcmed.2020.10.018","article-title":"Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through TIM-3","volume":"52","author":"Cheng","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0260","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/CMAR.S210568","article-title":"Malignant ascite-derived extracellular vesicles inhibit T cell activity by upregulating Siglec-10 expression","volume":"11","author":"Li","year":"2019","journal-title":"Cancer. Manag. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0265","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.bcp.2023.115445_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101334","article-title":"TIM-3 shuttled by MV3 cells-secreted exosomes inhibits CD4+ T cell immune function and induces macrophage M2 polarization to promote the growth and metastasis of melanoma cells","volume":"18","author":"Li","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fimmu.2017.00851","article-title":"Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis","volume":"8","author":"Greisen","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0280","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","article-title":"A novel soluble form of TIM-3 associated with severe graft-versus-host disease","volume":"19","author":"Hansen","year":"2013","journal-title":"Biol. Blood. Marrow. Transplant."},{"key":"10.1016\/j.bcp.2023.115445_b0285","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CMAR.S162478","article-title":"Highly elevated soluble TIM-3 levels correlate with increased hepatocellular carcinoma risk and poor survival of hepatocellular carcinoma patients in chronic hepatitis B virus infection","volume":"10","author":"Li","year":"2018","journal-title":"Cancer. Manag. Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115445_b0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CJI.0000000000000303","article-title":"Identification of Different Form TIM-3 Proteins by a Unique Set of TIM-3 Monoclonal Antibodies","volume":"43","author":"Wang","year":"2020","journal-title":"J. Immunother."},{"key":"10.1016\/j.bcp.2023.115445_b0295","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbamcr.2013.11.014","article-title":"Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine","volume":"1843","author":"Schweigert","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.bcp.2023.115445_b0300","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/febs.12583","article-title":"T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding","volume":"281","author":"Dewitz","year":"2014","journal-title":"FEBS. J."},{"key":"10.1016\/j.bcp.2023.115445_b0305","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.488478","article-title":"A disintegrin and metalloprotease (ADAM) 10 and ADAM17 are major sheddases of T cell immunoglobulin and mucin domain 3 (TIM-3)","volume":"288","author":"M\u00f6ller-Hackbarth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115445_b0310","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.176.3.1411","article-title":"Soluble form of T cell Ig mucin 3 is an inhibitory molecule in T cell-mediated immune response","volume":"176","author":"Geng","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0315","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.00006-15","article-title":"Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression","volume":"89","author":"Clayton","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2023.115445_b0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","article-title":"The TIM-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells","volume":"22","author":"Gon\u00e7alves Silva","year":"2017","journal-title":"EBioMedicine."},{"key":"10.1016\/j.bcp.2023.115445_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101042","article-title":"The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor TIM-3 in infected CD4+ T cells","volume":"297","author":"Jacob","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115445_b0330","doi-asserted-by":"crossref","first-page":"e22892","DOI":"10.1097\/MD.0000000000022892","article-title":"T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients","volume":"99","author":"Matsumoto","year":"2020","journal-title":"Medicine. (Baltimore)."},{"key":"10.1016\/j.bcp.2023.115445_b0335","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.3390\/cancers13143629","article-title":"Development of Multidrug Resistance in Acute Myeloid Leukemia Is Associated with Alterations of the LPHN1\/GAL-9\/TIM-3 Signaling Pathway","volume":"13","author":"Kocibalova","year":"2021","journal-title":"Cancers. (Basel)."},{"issue":"12","key":"10.1016\/j.bcp.2023.115445_b0340","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/cancers13123034","article-title":"Soluble Programmed Death Ligand-1 (sPD-L1): A Pool of Circulating Proteins Implicated in Health and Diseases","volume":"13","author":"Bailly","year":"2021","journal-title":"Cancers. (Basel)."},{"issue":"7","key":"10.1016\/j.bcp.2023.115445_b0345","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317715643","article-title":"TIM-3 as a diagnostic and prognostic biomarker of osteosarcoma","volume":"39","author":"Ge","year":"2017","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.bcp.2023.115445_b0350","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2021-1379","article-title":"The diagnostic value of soluble TIM-3 in oral squamous cell carcinoma","author":"Lu","year":"2022","journal-title":"Future. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101384","article-title":"Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1\/PD-L1 and TIM-3 are markedly increased in basal cell carcinoma","volume":"19","author":"Malinga","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0360","doi-asserted-by":"crossref","first-page":"e24224","DOI":"10.1002\/jcla.24224","article-title":"A comprehensive profiling of soluble immune checkpoints from the sera of patients with non-small cell lung cancer","volume":"36","author":"Peng","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bcp.2023.115445_b0365","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1158\/1078-0432.CCR-18-4142","article-title":"Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis","volume":"25","author":"Datar","year":"2019","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0370","article-title":"Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0375","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/jpm10040208","article-title":"Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients","volume":"10","author":"Zizzari","year":"2020","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0380","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s40425-019-0810-y","article-title":"Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients","volume":"7","author":"Wang","year":"2019","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.bcp.2023.115445_b0385","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s12957-022-02810-z","article-title":"High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer","volume":"20","author":"Mollavelioglu","year":"2022","journal-title":"World. J. Surg. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0390","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3892\/ol.2022.13318","article-title":"Prognostic significance of the expression levels of T-cell immunoglobulin mucin-3 and its ligand galectin-9 for relapse-free survival in triple-negative breast cancer","volume":"23","author":"Yoshikawa","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2023.115445_b0395","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3389\/fimmu.2019.01594","article-title":"The TIM-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer","volume":"10","author":"Yasinska","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molimm.2020.10.002","article-title":"Significance of TIM-3 expression by CD4+ and CD8+ T lymphocytes in tumor-draining lymph nodes from patients with breast cancer","volume":"128","author":"Shariati","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0405","unstructured":"Cheng S, Han F, Xu Y, Qu T, Ju Y. Expression of TIM-3 in breast cancer tissue promotes tumor progression. Int J Clin Exp Pathol. 2018;11:1157-1166. Erratum in Int J Clin Exp Pathol. 2021;14:855."},{"key":"10.1016\/j.bcp.2023.115445_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.579351","article-title":"TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation","volume":"11","author":"Zang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823842","article-title":"Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules","volume":"13","author":"Rapoport","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0420","doi-asserted-by":"crossref","first-page":"e1184","DOI":"10.1002\/cti2.1184","article-title":"Age-related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer","volume":"9","author":"Berben","year":"2020","journal-title":"Clin. Transl. Immunology."},{"key":"10.1016\/j.bcp.2023.115445_b0425","doi-asserted-by":"crossref","first-page":"102088","DOI":"10.18632\/oncotarget.22141","article-title":"High TIM-3 expression on AML blasts could enhance chemotherapy sensitivity","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bcp.2023.115445_b0430","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/16078454.2020.1738097","article-title":"Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients","volume":"25","author":"Yegin","year":"2020","journal-title":"Hematology."},{"key":"10.1016\/j.bcp.2023.115445_b0435","doi-asserted-by":"crossref","unstructured":"Brauneck F, Weimer P, Schulze Zur Wiesch J, Weisel K, Leypoldt L, Vohwinkel G, Fritzsche B, Bokemeyer C, Wellbrock J, Fiedler W. Bone Marrow-Resident V\u03b41 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma. Front Med (Lausanne). 2021;8:763773.","DOI":"10.3389\/fmed.2021.763773"},{"key":"10.1016\/j.bcp.2023.115445_b0440","article-title":"TIM-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0445","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/2326-6066.CIR-15-0055","article-title":"T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy","volume":"4","author":"Chung","year":"2016","journal-title":"Cancer. Immunol. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0450","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbmt.2019.08.009","article-title":"T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma","volume":"26","author":"Lucas","year":"2020","journal-title":"Biol. Blood. Marrow. Transplant."},{"key":"10.1016\/j.bcp.2023.115445_b0455","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3892\/mmr.2017.6670","article-title":"Noninvasive detection of acute renal allograft rejection by measurement of soluble TIM-3 in urine","volume":"16","author":"Chen","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2023.115445_b0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trim.2017.07.002","article-title":"High expression of TIM-3 and KIM-1 in blood and urine of renal allograft rejection patients","volume":"43\u201344","author":"Shahbaz","year":"2017","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0465","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trim.2018.10.007","article-title":"Sequential monitoring of TIM-3 mRNA expression in blood and urine samples of renal transplant recipients","volume":"54","author":"Shahbaz","year":"2019","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0470","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.intimp.2018.01.008","article-title":"Soluble TIM-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study","volume":"55","author":"Li","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115445_b0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2021.12.010","article-title":"Soluble TIM-3\/Gal-9 as predictors of adverse outcomes after kidney transplantation: A cohort study","volume":"102","author":"Yan","year":"2022","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bcp.2023.115445_b0480","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3389\/fimmu.2019.03158","article-title":"Preliminary Results of a Combined Score Based on sIL2-R\u03b1 and TIM-3 Levels Assayed Early After Hematopoietic Transplantation","volume":"10","author":"Leotta","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115445_b0485","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/08916934.2021.1891535","article-title":"Elevated soluble TIM-3 correlates with disease activity of systemic lupus erythematosus","volume":"54","author":"Zhao","year":"2021","journal-title":"Autoimmunity."},{"key":"10.1016\/j.bcp.2023.115445_b0490","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41385-022-00487-x","article-title":"A Notch\/STAT3-driven Blimp-1\/c-Maf-dependent molecular switch induces IL-10 expression in human CD4+ T cells and is defective in Croh\u0144s disease patients","volume":"15","author":"Ahlers","year":"2022","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0495","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3892\/etm.2022.11543","article-title":"Clinical value of the sTIM\u20133 level in chronic kidney disease","volume":"24","author":"Chen","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0500","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1189\/jlb.3HI0117-005RR","article-title":"Frontline Science: TIM-3-mediated dysfunctional engulfment of apoptotic cells in SLE","volume":"102","author":"Zhao","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcp.2023.115445_b0505","doi-asserted-by":"crossref","first-page":"168","DOI":"10.12659\/MSMBR.910949","article-title":"Association of Serum T cell Immunoglobulin Domain and Mucin-3 and Interleukin-17 with Systemic Lupus Erythematosus","volume":"24","author":"Jin","year":"2018","journal-title":"Med. Sci. Monit. Basic. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0510","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/jcm9113563","article-title":"Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus","volume":"9","author":"Asano","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0515","doi-asserted-by":"crossref","first-page":"e0260254","DOI":"10.1371\/journal.pone.0260254","article-title":"Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis","volume":"16","author":"Matsumoto","year":"2021","journal-title":"PLoS. One."},{"key":"10.1016\/j.bcp.2023.115445_b0520","first-page":"34","article-title":"T-cell immunoglobulin and mucin domain 3 is upregulated in rheumatoid arthritis, but insufficient in controlling inflammation","volume":"11","author":"Skejoe","year":"2022","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0525","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13075-020-02263-3","article-title":"Elevated serum levels of checkpoint molecules in patients with adult Still's disease","volume":"22","author":"Fujita","year":"2020","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2023.115445_b0530","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41390-021-01588-2","article-title":"Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes","volume":"90","author":"Sag","year":"2021","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-021-02527-6","article-title":"Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)","volume":"23","author":"Matsumoto","year":"2021","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.bcp.2023.115445_b0540","doi-asserted-by":"crossref","unstructured":"Pic\u00f3n C, Tejeda-Velarde A, Fern\u00e1ndez-Velasco JI, Comabella M, \u00c1lvarez-Lafuente R, Quintana E, Sainz de la Maza S, Monreal E, Villarrubia N, \u00c1lvarez-Cerme\u00f1o JC, Dom\u00ednguez-Mozo MI, Rami\u00f3-Torrent\u00e0 L, Rodr\u00edguez-Mart\u00edn E, Rold\u00e1n E, Aladro Y, Medina S, Espi\u00f1o M, Masjuan J, Matute-Blanch C, Mu\u00f1oz-San Mart\u00edn M, Espejo C, Guaza C, Muriel A, Costa-Frossard L, Villar LM. Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis. Front Immunol. 2021;12:685139.","DOI":"10.3389\/fimmu.2021.685139"},{"key":"10.1016\/j.bcp.2023.115445_b0545","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2019.00835","article-title":"Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis","volume":"10","author":"Lavon","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0550","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2018.08.004","article-title":"CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients","volume":"323","author":"Mohammadzadeh","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2023.115445_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109152","article-title":"Mesenchymal stem cell transplantation alleviates Sj\u00f6gren's syndrome symptoms by modulating TIM-3 expression","volume":"111","author":"Sun","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115445_b0560","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/1346-8138.13610","article-title":"Clinical significance of serum soluble T-cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: Association with disease severity","volume":"44","author":"Chiba","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bcp.2023.115445_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.819790","article-title":"Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients","volume":"12","author":"Kgokolo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0570","doi-asserted-by":"crossref","first-page":"13","DOI":"10.55563\/clinexprheumatol\/6y0bjb","article-title":"TIM-3 regulates the NETs-mediated dendritic cell activation in myeloperoxidase-ANCA-associated vasculitis","volume":"39","author":"Su","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2023.115445_b0575","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard-2022-222479","article-title":"Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission","volume":"82","author":"Gamerith","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2023.115445_b0580","doi-asserted-by":"crossref","first-page":"21319","DOI":"10.1038\/s41598-022-25466-x","article-title":"Soluble immune checkpoint molecules in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"12","author":"Pyo","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115445_b0585","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2022.06.007","article-title":"The Inconvenient Truth of Primary Biliary Cholangitis\/Autoimmune Hepatitis Overlap Syndrome","volume":"26","author":"Hussain","year":"2022","journal-title":"Clin. Liver. Dis."},{"key":"10.1016\/j.bcp.2023.115445_b0590","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/2211-5463.13148","article-title":"TIM-3 suppresses autoimmune hepatitis via the p38\/MKP-1 pathway in Th17 cells","volume":"11","author":"Wu","year":"2021","journal-title":"FEBS. Open. Bio."},{"key":"10.1016\/j.bcp.2023.115445_b0595","doi-asserted-by":"crossref","first-page":"e0238540","DOI":"10.1371\/journal.pone.0238540","article-title":"Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis","volume":"15","author":"Migita","year":"2020","journal-title":"PLoS. One."},{"key":"10.1016\/j.bcp.2023.115445_b0600","doi-asserted-by":"crossref","first-page":"e16924","DOI":"10.1097\/MD.0000000000016924","article-title":"Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis","volume":"98","author":"Matsuoka","year":"2019","journal-title":"Medicine. (Baltimore)."},{"key":"10.1016\/j.bcp.2023.115445_b0605","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12876-022-02537-x","article-title":"Serum soluble T cell immunoglobulin mucin domain-3 as an early predictive marker for severity of acute pancreatitis; a retrospective analysis","volume":"22","author":"Wang","year":"2022","journal-title":"BMC. Gastroenterol."},{"key":"10.1016\/j.bcp.2023.115445_b0610","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.clim.2009.09.012","article-title":"Involvement of T cell Ig Mucin-3 (TIM-3) in the negative regulation of inflammatory bowel disease","volume":"134","author":"Li","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0615","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clim.2012.09.001","article-title":"Dysregulated TIM-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis","volume":"145","author":"Shi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0620","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clim.2015.07.008","article-title":"TIM-3 promotes intestinal homeostasis in DSS colitis by inhibiting M1 polarization of macrophages","volume":"160","author":"Jiang","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.micpath.2018.12.043","article-title":"Fecal bacteria from ulcerative colitis patients downregulate TIM-3-mediated inhibitory effects on monocytes in vitro","volume":"128","author":"Wang","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bcp.2023.115445_b0630","article-title":"Patients With Microscopic Colitis Have Altered Levels of Inhibitory and Stimulatory Biomarkers in Colon Biopsies and Sera Compared to Non-inflamed Controls","volume":"8","author":"Lushnikova","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.bcp.2023.115445_b0635","first-page":"370","article-title":"Expression of TIM-3, Human \u03b2-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy","volume":"9","author":"Kim","year":"2015","journal-title":"Gut. Liver."},{"key":"10.1016\/j.bcp.2023.115445_b0640","first-page":"765","article-title":"TIM-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer Disease","volume":"18","author":"Naghavi-Alhosseini","year":"2017","journal-title":"Asian. Pac. J. Cancer. Prev."},{"key":"10.1016\/j.bcp.2023.115445_b0645","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/QAD.0000000000002165","article-title":"CHERUB Investigators. Soluble plasma programmed death 1 (PD-1) and TIM-3 in primary HIV infection","volume":"33","author":"Zilber","year":"2019","journal-title":"AIDS."},{"key":"10.1016\/j.bcp.2023.115445_b0650","doi-asserted-by":"crossref","first-page":"ofaa033","DOI":"10.1093\/ofid\/ofaa033","article-title":"Soluble T-Cell Immunoglobulin Mucin Domain-3 Is Associated With Hepatitis C Virus Coinfection and Low-Grade Inflammation During Chronic Human Immunodeficiency Virus Infection","volume":"7","author":"Hoel","year":"2020","journal-title":"Open. Forum. Infect. Dis."},{"key":"10.1016\/j.bcp.2023.115445_b0655","doi-asserted-by":"crossref","unstructured":"Paul R, Cho K, Bolzenius J, Sacdalan C, Ndhlovu LC, Trautmann L, Krebs S, Tipsuk S, Crowell TA, Suttichom D, Colby DJ, Premeaux TA, Phanuphak N, Chan P, Kroon E, Vasan S, Hsu D, Carrico A, Valcour V, Ananworanich J, Robb ML, Ake JA, Sriplienchan S, Spudich S; RV254\/SEARCH 010 Study Team. Individual Differences in CD4\/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection. Psychosom Med. 2022;84:976-983.","DOI":"10.1097\/PSY.0000000000001129"},{"key":"10.1016\/j.bcp.2023.115445_b0660","article-title":"Increase in Serum Soluble TIM-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.bcp.2023.115445_b0665","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2020.09.007","article-title":"Elevated plasma sTIM-3 levels in patients with severe COVID-19","volume":"147","author":"Ueland","year":"2021","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0670","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/biom12030445","article-title":"Circulating Levels of PD-L1, TIM-3 and MMP-7 Are Promising Biomarkers to Differentiate COVID-19 Patients That Require Invasive Mechanical Ventilation","volume":"12","author":"Chavez-Galan","year":"2022","journal-title":"Biomolecules."},{"key":"10.1016\/j.bcp.2023.115445_b0675","article-title":"Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0680","first-page":"527","article-title":"High Levels of TNF-\u03b1 and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection","volume":"11","author":"Ramon-Luing","year":"2021","journal-title":"Life. (Basel)."},{"key":"10.1016\/j.bcp.2023.115445_b0685","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12879-018-3593-8","article-title":"Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria","volume":"18","author":"Otterdal","year":"2018","journal-title":"BMC. Infect. Dis."},{"key":"10.1016\/j.bcp.2023.115445_b0690","first-page":"11","article-title":"Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease","volume":"1870","author":"Herrmann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0695","first-page":"3809","article-title":"Upregulation of TIM-3 on CD4(+) T cells is associated with Th1\/Th2 imbalance in patients with allergic asthma","volume":"8","author":"Tang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0700","first-page":"517","article-title":"levated Expression of TIM-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma","volume":"17","author":"Mosayebian","year":"2018","journal-title":"Iran. J. Allergy. Asthma. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0705","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0194599818774560","article-title":"TIM-3-Expressing Mast Cells Are Present in Chronic Rhinosinusitis with Nasal Polyps","volume":"159","author":"Corredera","year":"2018","journal-title":"Otolaryngol. Head. Neck. Surg."},{"key":"10.1016\/j.bcp.2023.115445_b0710","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11596-013-1145-4","article-title":"Dexamethasone reduces IL-17 and TIM-3 expression in BALF of asthmatic mice","volume":"33","author":"Lu","year":"2013","journal-title":"J. Huazhong. Univ. Sci. Technolog. Med. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0715","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10753-012-9580-0","article-title":"Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness","volume":"36","author":"Lu","year":"2013","journal-title":"Inflammation."},{"key":"10.1016\/j.bcp.2023.115445_b0720","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.21037\/atm-21-5648","article-title":"The expression and function of programmed death-ligand 1 and related cytokines in neutrophilic asthma","volume":"9","author":"Ren","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0725","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.alit.2016.08.008","article-title":"Inverse correlation of soluble programmed cell death-1 ligand-1 (sPD-L1) with eosinophil count and clinical severity in allergic rhinitis patients","volume":"66","author":"Nasiri Kalmarzi","year":"2017","journal-title":"Allergol. Int."},{"key":"10.1016\/j.bcp.2023.115445_b0730","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/eji.201948382","article-title":"Immune checkpoint molecules in pregnancy: Focus on regulatory T cells","volume":"50","author":"Zhang","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115445_b0735","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/imr.13073","article-title":"Next generation of immune checkpoint molecules in maternal-fetal immunity","volume":"308","author":"Zhao","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bcp.2023.115445_b0740","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1080\/14767058.2019.1706471","article-title":"Soluble T cell immunoglobulin mucin domain 3 (sTIM-3) in maternal sera: a potential contributor to immune regulation during pregnancy","volume":"34","author":"Grossman","year":"2021","journal-title":"J. Matern. Fetal. Neonatal. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0745","first-page":"8812","article-title":"Soluble costimulatory molecule sTIM3 regulates the differentiation of Th1 and Th2 in patients with unexplained recurrent spontaneous abortion","volume":"8","author":"Wu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0750","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.humimm.2022.07.004","article-title":"Expression level of immune checkpoint inhibitory factors in preeclampsia","volume":"83","author":"Madadi","year":"2022","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115445_b0755","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s43032-021-00675-3","article-title":"Involvement of the TIM-3 Pathway in the Pathogenesis of Pre-Eclampsia","volume":"28","author":"Wang","year":"2021","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0760","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.placenta.2021.08.060","article-title":"The abnormal expression of TIM-3 is involved in the regulation of myeloid-derived suppressor cells and its correlation with preeclampsia","volume":"114","author":"Dong","year":"2021","journal-title":"Placenta."},{"key":"10.1016\/j.bcp.2023.115445_b0765","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41419-018-1251-0","article-title":"Blockade of CTLA-4 and TIM-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4+T cells","volume":"10","author":"Wang","year":"2019","journal-title":"Cell. Death. Dis."},{"key":"10.1016\/j.bcp.2023.115445_b0770","doi-asserted-by":"crossref","first-page":"e0259563","DOI":"10.1371\/journal.pone.0259563","article-title":"Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs","volume":"16","author":"Xu","year":"2021","journal-title":"PLoS. One."},{"key":"10.1016\/j.bcp.2023.115445_b0775","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.3390\/ijms22094653","article-title":"Isolation of Small Extracellular Vesicles from Human Sera","volume":"22","author":"Ma\u0142ys","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0780","first-page":"1201","article-title":"Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)","volume":"19","author":"Homayouni","year":"2016","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"10.1016\/j.bcp.2023.115445_b0785","doi-asserted-by":"crossref","first-page":"2929605","DOI":"10.1155\/2022\/2929605","article-title":"Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3","volume":"2022","author":"Xia","year":"2022","journal-title":"Comput. Math. Methods. Med."},{"issue":"6","key":"10.1016\/j.bcp.2023.115445_b0790","doi-asserted-by":"crossref","first-page":"e23248","DOI":"10.1002\/jcla.23248","article-title":"Soluble TIM3 detection by time-resolved fluorescence immunoassay and its application in membranous nephropathy","volume":"34","author":"Chen","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bcp.2023.115445_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116505","article-title":"Analytical methods for the detection of PD-1\/PD-L1 and other molecules related to immune checkpoints","volume":"146","author":"Wang","year":"2022","journal-title":"Trends. Anal. Chem"},{"key":"10.1016\/j.bcp.2023.115445_b0800","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1074\/mcp.RA117.000037","article-title":"Quantitative Mass Spectrometry Analysis of PD-L1 Protein Expression, N-glycosylation and Expression Stoichiometry with PD-1 and PD-L2 in Human Melanoma","volume":"16","author":"Morales-Betanzos","year":"2017","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.bcp.2023.115445_b0805","doi-asserted-by":"crossref","first-page":"10144","DOI":"10.1038\/s41598-019-46548-3","article-title":"Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasma","volume":"9","author":"Goto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115445_b0810","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1039\/C9AN01450K","article-title":"Single droplet detection of immune checkpoints on a multiplexed electrohydrodynamic biosensor","volume":"144","author":"Wuethrich","year":"2019","journal-title":"Analyst."},{"key":"10.1016\/j.bcp.2023.115445_b0815","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/bios11060202","article-title":"Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases","volume":"11(6)","author":"Torrente-Rodr\u00edguez","year":"2021","journal-title":"Biosensors. (Basel)"},{"key":"10.1016\/j.bcp.2023.115445_b0820","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/bios11120500","article-title":"On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy","volume":"11","author":"Mummareddy","year":"2021","journal-title":"Biosensors. (Basel)."},{"key":"10.1016\/j.bcp.2023.115445_b0825","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.14440\/jbm.2019.283","article-title":"Detection of clinically relevant immune checkpoint markers by multicolor flow cytometry","volume":"6","author":"Cunningham","year":"2019","journal-title":"J. Biol. Methods."},{"key":"10.1016\/j.bcp.2023.115445_b0830","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/dna.2013.2116","article-title":"The expression of TIM-3 in peripheral blood of ovarian cancer","volume":"32","author":"Wu","year":"2013","journal-title":"DNA. Cell. Biol."},{"key":"10.1016\/j.bcp.2023.115445_b0835","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-18-4175","article-title":"TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer","volume":"25","author":"Fucikova","year":"2019","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0840","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3892\/ol.2022.13308","article-title":"Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer","volume":"23","author":"James","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bcp.2023.115445_b0845","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/cells11060964","article-title":"Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by \u03b3\u03b4 T Cells in Ovarian Cancer","volume":"11","author":"Weimer","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.bcp.2023.115445_b0850","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.946319","article-title":"Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?","volume":"12","author":"Fanale","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2023.115445_b0855","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211056505","article-title":"Analysis of human glioma-associated co-inhibitory immune checkpoints in glioma microenvironment and peripheral blood","volume":"35","author":"Shen","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115445_b0860","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.800928","article-title":"Galectin-9\/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p\/19q Codeletion","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0865","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.678400","article-title":"Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target","volume":"12","author":"Ponce de Le\u00f3n","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0870","doi-asserted-by":"crossref","first-page":"eabc2728","DOI":"10.1126\/sciimmunol.abc2728","article-title":"Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding","volume":"5","author":"Andrews","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0875","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fcell.2018.00153","article-title":"Renal ADAM10 and 17: Their Physiological and Medical Meanings","volume":"6","author":"Kato","year":"2018","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.bcp.2023.115445_b0880","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.leukres.2013.04.014","article-title":"Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression","volume":"37","author":"Twito","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bcp.2023.115445_b0885","doi-asserted-by":"crossref","first-page":"e0152073","DOI":"10.1371\/journal.pone.0152073","article-title":"Characterization of CD200 Ectodomain Shedding","volume":"11","author":"Wong","year":"2016","journal-title":"PLoS. One."},{"key":"10.1016\/j.bcp.2023.115445_b0890","doi-asserted-by":"crossref","first-page":"e150750","DOI":"10.1172\/JCI150750","article-title":"CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis","volume":"132","author":"Morgan","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115445_b0895","doi-asserted-by":"crossref","first-page":"ltab025","DOI":"10.1093\/immadv\/ltab025","article-title":"Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity","volume":"2","author":"Burnell","year":"2021","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.bcp.2023.115445_b0900","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.615317","article-title":"LAG3's Enigmatic Mechanism of Action","volume":"11","author":"Graydon","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0905","doi-asserted-by":"crossref","first-page":"3939720","DOI":"10.1155\/2019\/3939720","article-title":"Analysis of Plasma EBV-DNA and Soluble Checkpoint Proteins in Nasopharyngeal Carcinoma Patients after Definitive Intensity-Modulated Radiotherapy","volume":"2019","author":"Ruan","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bcp.2023.115445_b0910","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/jpm11070651","article-title":"The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study","volume":"11","author":"Botticelli","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bcp.2023.115445_b0915","doi-asserted-by":"crossref","first-page":"1926762","DOI":"10.1080\/2162402X.2021.1926762","article-title":"Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients","volume":"10","author":"Machiraju","year":"2021","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bcp.2023.115445_b0920","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2369-14-23","article-title":"Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease","volume":"14","author":"Kurose","year":"2013","journal-title":"BMC. Nephrol."},{"key":"10.1016\/j.bcp.2023.115445_b0925","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940835","article-title":"Early detection of soluble CD27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients","volume":"13","author":"Penatzer","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0930","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.arbres.2021.01.035","article-title":"Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization","volume":"58","author":"Pan","year":"2022","journal-title":"Arch. Bronconeumol."},{"key":"10.1016\/j.bcp.2023.115445_b0935","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10875-022-01318-1","article-title":"Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency","volume":"42","author":"Fraz","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0940","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.molimm.2021.04.014","article-title":"Modulation of CXCR1 and CXCR3 expression on NK cells via TIM-3 in a murine model of primary biliary cholangitis","volume":"135","author":"Xu","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2023.115445_b0945","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.alcohol.2021.10.002","article-title":"Characteristics of immune checkpoint regulators and potential role of soluble TIM-3 and LAG-3 in male patients with alcohol-associated liver disease","volume":"98","author":"Fadriquela","year":"2022","journal-title":"Alcohol."},{"key":"10.1016\/j.bcp.2023.115445_b0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155794","article-title":"Soluble T cell immunoglobulin and mucin-domain containing protein 3 in children hospitalized with pneumonia in resource-limited settings","volume":"151","author":"Ahmed","year":"2022","journal-title":"Cytokine."},{"key":"10.1016\/j.bcp.2023.115445_b0955","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tan.12653","article-title":"Plasma soluble TIM-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane TIM-3 on monocytes","volume":"86","author":"Ren","year":"2015","journal-title":"Tissue. Antigens."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:41:49Z","timestamp":1757770909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":191,"alternative-id":["S0006295223000369"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115445","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115445"}}